Subscribe
Contact Us
About Us
Advertise
Home
News
News from MM&M
Off the Wire
Newsletters
PMD Profiles
Agency Creative Showcase
Publication Connection
PMD Marketplace
Careers
About Us
Additional Resources
MM&M
MM&M Jobs
MAHF
Voi Consulting
Advertise
Subscribe
Get Listed
Additional Resources
RSS
|
Login
|
Register
Collaboration
Novo Nordisk Inc. Announces Exclusive Agreement With Upsher-Smith Laboratories, Inc. to Market Vagifem® 10 mcg
August 23, 2010
Vagifem® 10 mcg replaces Vagifem® 25 mcg dose
Affymax® Receives $5 Million Milestone Payment on Initiation of Phase 3 Clinical Trials for Hematide in Japan
March 10, 2010
Affymax and Takeda will co-commercialize the product in the U.S.
Alexza and Biovail Form Collaboration to Develop and Commercialize AZ-004 (Staccato(R) Loxapine) in North America
February 10, 2010
Alexza to get upfront cash payment $40 Million
Pfizer and Strides Arcolab to Collaborate on Generic Products
January 06, 2010
Pfizer commited to becoming one of the top players in the injectables market
Idera Pharmaceuticals Announces Termination of Asthma and Allergy Research Collaboration Agreement
November 25, 2009
Idera to Regain Full Rights to IMO-2134 (formerly QAX935)
Bristol-Myers Squibb and Alder Biopharmaceuticals Enter Global Agreement on Rheumatoid Arthritis Biologic
November 10, 2009
Bristol-Myers Squibb buys rights to RA drug for $85 million
Transcept Announces Plans to Reduce Expenses by Decreasing Staff
August 18, 2009
Recent Completion of Purdue U.S. License and Collaboration Agreement
Zogenix and Astellas Enter Exclusive Co-Promotion Agreement in the US for Newly Approved Sumavel(TM) DosePro(TM)
August 03, 2009
Sumavel DosePro is expected to be commercially available in January 2010
Addex Achieves Second Milestone in Parkinson's Disease Collaboration With Merck & Company, Inc.
July 10, 2009
Data Confirm Non-Dopaminergic Approach to Treating Parkinson's Disease
MAP Pharmaceuticals Announces Termination of Pediatric Asthma Collaboration
July 09, 2009
Company to Suspend Development of UDB
Latest News
Sinobiomed Announces New Chief Executive Officer
Actavis Receives FDA Approval of Atomoxetine HCl Capsules
MonoSol Rx Announces Reckitt Benckiser FDA Approval of Suboxone® Sublingual Film for Treatment of Opioid Dependence
Biodel Announces Name Change for Lead Product Candidate
Pfizer to Acquire FoldRx Pharmaceuticals
GSK and Valeant Announce New U.S. FDA PDUFA Goal Date for Ezogabine
pSivida Announces Iluvien® Receives FDA Priority Review for Treatment of Diabetic Macular Edema
Medicis Announces Approval of Additional Strengths of Solodyn(R)
Meda acquires Alaven, a US specialty pharma company
Luminex Announces Commercial Launch of New Cystic Fibrosis Test
Most Popular
Most Emailed
Most Recent
Luminex Announces Commercial Launch of New Cystic Fibrosis Test
Novartis receives FDA approval of Tekamlo
Meda acquires Alaven, a US specialty pharma company
XenoPort Announces Changes to Executive Team
Actavis Receives FDA Approval of Atomoxetine HCl Capsules
GSK and Valeant Announce New U.S. FDA PDUFA Goal Date for Ezogabine
Pfizer to Acquire FoldRx Pharmaceuticals
Medicis Announces Approval of Additional Strengths of Solodyn(R)
pSivida Announces Iluvien® Receives FDA Priority Review for Treatment of Diabetic Macular Edema
MonoSol Rx Announces Reckitt Benckiser FDA Approval of Suboxone® Sublingual Film for Treatment of Opioid Dependence
Meda acquires Alaven, a US specialty pharma company
Novo Nordisk Creates 'App' to Help Doctors Dose Insulin, Supporting New Trend in Diabetes Care
Biodel Announces Name Change for Lead Product Candidate
GSK and Valeant Announce New U.S. FDA PDUFA Goal Date for Ezogabine
Medicis Announces Approval of Additional Strengths of Solodyn(R)
FDA Accepts Sanofi Pasteur's Application to Expand Indication of Menactra® Vaccine to Infants and Toddlers
Sinobiomed Announces New Chief Executive Officer
Actavis Receives FDA Approval of Atomoxetine HCl Capsules
Pfizer to Acquire FoldRx Pharmaceuticals
MonoSol Rx Announces Reckitt Benckiser FDA Approval of Suboxone® Sublingual Film for Treatment of Opioid Dependence
Sinobiomed Announces New Chief Executive Officer
Actavis Receives FDA Approval of Atomoxetine HCl Capsules
MonoSol Rx Announces Reckitt Benckiser FDA Approval of Suboxone® Sublingual Film for Treatment of Opioid Dependence
Biodel Announces Name Change for Lead Product Candidate
Pfizer to Acquire FoldRx Pharmaceuticals
GSK and Valeant Announce New U.S. FDA PDUFA Goal Date for Ezogabine
pSivida Announces Iluvien® Receives FDA Priority Review for Treatment of Diabetic Macular Edema
Medicis Announces Approval of Additional Strengths of Solodyn(R)
Meda acquires Alaven, a US specialty pharma company
Luminex Announces Commercial Launch of New Cystic Fibrosis Test
Popular Topics
Acquisition
Agency
Animal Health
Biopharmaceutical
Biotech
Business
Clinical Management
Collaboration
Diagnostic
Marketing & Communications
Medical Device
Medical Equipment
Merger
New Hire
New Hires
Personnel
Pharmaceutical
Pharmaceutical Products
Pipeline
Product Acquisition
Product Launch
Product Promotion
Regulatory
Regulatory Approval
Research & Development